Sitewide
New clues to breast cancer development in high-risk women
Physicians who treat women with the breast cancer susceptibility gene BRCA1 often remove their patients' ovaries to eliminate the source of estrogen they believe fuels cancer growth. Yet they also know that anti-estrogen therapies don't work to treat breast or ovarian cancer that might develop. That paradox has led scientists to question exactly how, or if, estrogen is involved in cancer development and whether removal of ovaries makes sense.
Similar Articles On This Topic:
- Mammography may increase breast cancer risk in some high-risk women
- UB played major role in study on drug that reduces breast cancer in high-risk women
- High-risk women reluctant to take tamoxifen to prevent breast cancer, U-M study finds
- Adding ultrasound to mammography may improve breast cancer detection in high-risk women
- Second breast cancer may be greater than thought for high-risk women without BRCA mutations
Popular Today:
Science 2.0:
Recent Articles:
Read Us On Your Kindle:
Create Your Own Releases:
Post new comment